… and may increase the risk of COVID-19. Therefore, androgen deprivation therapy (ADT) may
… effect of androgen deprivation therapy (ADT) on COVID-19 in patients with prostate cancer. …

… with COVID-19 and prostate cancer to determine the impact of ADT on COVID-19 clinical
outcomes. To our best knowledge, this is the largest study to report severity of COVID-19 in …

… COVID-19–related mortality rate observed among men than among women, is androgen
deprivation therapy … other androgen-targeted therapies in reducing COVID-19 infection severity. …

… the hypothesis that androgen-deprivation therapy (ADT) is an effective therapy in patients
with coronavirus disease 2019 (COVID-19) but may instead be used for prophylactic treatment. …

… of patients treated for COVID-19 in our institution who had a previous diagnosis of PC.
We analyzed the influence of exposure of ADT on the presence of severe course of COVID-19. …

… COVID-19 and PCa at 7 US medical centers to determine the impact of ADT on COVID-19–…
To our best knowledge, this is one of the larger studies to report the severity of COVID-19 in …

… for differences in COVID-19 outcome in men and women. We hypothesized that men treated
with androgen deprivation therapy (ADT) have lower incidence and severity of COVID-19. …

… androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory
syndrome coronavirus 2 (… be a potential treatment for coronavirus disease 2019 (COVID-19). The …

… may reduce infection rates and improve outcomes for COVID-19. In the … by COVID-19. The
aim was to estimate the impact of androgen deprivation therapy on mortality from COVID-19 in …

… facilitate entrance of the severe acute respiratory syndrome coronavirus 2 into respiratory …
corona virus disease (COVID-19). Androgen deprivation therapy (ADT) could possibly improve …